Table 1b.
Patient overview
| Case No. | 5-year risk at Viscum album initiationc | Outcomed | |
|---|---|---|---|
| Recurrence risk, % | Progression risk, % | ||
| 1a | 62 | 25 | 7 years tumor-free since V album treatment |
| 2a | 78 | 17 | 5 years tumor-free since V album treatment |
| 3a | 62 | 6 | 32 months tumor-free since V album treatment |
| 4a | 62 | 6 | Recurrences after V album treatment; now 35 months tumor-free |
| 5a | 62 | 6 | 5 years tumor-free; was already 18 months tumor-free before V album treatment |
| 6a | 62 | 45 | Stage Tis 4 years after V album treatment; now 30 months tumor-free |
| 7a | 78 | 45 | Recurrences after radiochemotherapy; tumor-free since BCG and V album treatment (6 years since V album) |
| 8b | Very high risk | Very high risk | 5 years tumor-free since V album treatment and BCG despite muscle-invasive cancer |